Insider trading investigations are latest hurdle for Converium

The Swiss Exchange (SWX) has completed a probe into possible insider trading at Converium according to Reuters. The investigation followed the announcement in July of a $385 million hole in reserves which has resulted in a two-thirds fall in the share price. The U.S. Securities and Exchange Commission is carrying out a similar investigation, according to the company’s SEC filing on October 6th.

The SWX probe was conducted to determine whether company insiders traded Converium shares before the reinsurer revealed its shortcomings in reserves. It has declined to comment on the outcome of the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Register

Want to know what’s included in our free registration? Click here

Already have an account? Sign in here

FCA stops potential ghost broker from trading

The Financial Conduct Authority has stopped Arthur Temlett, trading as Abacus Insurance Consultants, from carrying out any regulated activities, including acting as an insurance broker.

City minister Siddiq is replaced by Reynolds

Less than 24 hours before she was due to appear at the British Insurance Brokers’ Association’s Manifesto launch, Tulip Siddiq has resigned as Treasury minister and been replaced by Labour MP Emma Reynolds.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here